GENE ONLINE|News &
Opinion
Blog

AI
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
Taiwan’s Biotech Industry Directives: Six Strategic Aspects of AI Empowerment, Smart Healthcare, and Global Expansion
2024-08-29
BioAro’s PanOmiQ Tech Sets New Standard with 100% Accuracy in Whole Genome Sequencing
2024-08-23
AusBiotech on Funding, Regulatory Navigation, International Expansion, and Clinical Trial Development in Australia’s Biotech Industry
2024-08-22
Precision Medicine: Transforming Healthcare Through Genetics and AI
2024-07-27
AI Revolutionizing Pharma: Transformative Approaches in Drug Discovery and Clinical Trials
2024-07-27
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
AI-Driven Breakthroughs in Drug Discovery and Treatment Optimization
2024-04-02
AI-Designed Antibodies: A Revolution in Antibody Drug Discovery
2024-03-20
Mayo Clinic Researchers Invent Hypothesis-Driven AI for Cancer Research Breakthroughs
2024-03-14
Tech Titans, ASUS, Quanta and Gigabyte, Anticipate Groundbreaking Medical AI Developments at IBMI 2024 Annual General Meeting
2024-03-11
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
Lunit AI Solutions to Power Samsung’s X-ray Devices for Advanced Chest Screening
2024-01-16
1 2 3 7
LATEST
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
2024-09-04
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
ESMO Introduces New Framework for Evaluating Tumor-Agnostic Potential of Cancer Treatments
2024-09-03
EVENT
2024-09-11
2024 Bio Asia Pacific
Bangkok, Thailand
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top